Unverified50% confidenceOpinionExact time
In applying the product liability framework to generative AI, the disputes usually center on two points — whether model output constitutes a "product defect," and whether disclaimers constitute "adequate warnings."
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/28/2026
First Seen
Valid until: 1/26/2027
Sources
Related Entities
Related Claims
UnverifiedFor the vast majority of enterprises, the right decision for generative AI development is not simply 'mindlessly calling an API' or 'training a model from scratch', but depends on data sensitivity, risk tolerance and product goals.80% similarVerifiedThe deviation between an AI system's execution objective and the designer's true intent is classified in AI safety research as Goal Misalignment.75% similarUnverifiedEnterprise AI products should have anti-hallucination mechanisms built in at the architecture level, including mandatory source citation, confidence threshold settings, and explicit refusal to answer questions that cannot be determined.74% similarUnverifiedFor health AI product development teams, safety evaluation cannot rely only on clinical case libraries and must introduce real conversations with demographic backgrounds; referral mechanisms need to be upgraded from soft prompts to hard rules; and for high-risk intents such as medication, dosage, and self-diagnosis, there should be dedicated protections independent of the general safety layer.74% similarUnverifiedThe self-evaluation dilemma is a core problem in AI safety governance: model developers are both players and referees, and the safety reports they publish are inevitably questioned as involving selective disclosure.73% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1105700API
curl https://kongchang.com/api/v1/knowledge/claims/1105700MCP
get_claim(id=1105700)